Dendritic cells and TNF-Related apoptosis inducing ligand (TRAIL) represent new possibilities for sepsis treatment
Insights in Clinical and Cellular Immunology · 2017
DOI: 10.29328/journal.hcci.1001001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Insights in Clinical and Cellular Immunology, 2017. Verfasst von P Ganova. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Sepsis refers to a generalized infl ammatory response of the organism to an infection or to bacterial products in circulation, rather than the development of an infection per se.Despite recent advances in clinical practice and overall medical care, sepsis remains a great health care problem and is still the most common cause of death in critically ill patients with infection.We suppose that during the course of sepsis the expression of TRAIL in different organs correlates with acute mortality and further development of multiple organ dysfunction syndrome (MODS).It is expected that dendritic cells (DCs) might become targets for apoptotic processes in a result of elevated TRAIL expression.This hypothesis is a bias for detailed investigations for in vivo studies in animal models and for in vitro studies of septic patients.
Zitieren
APA
Ganova, P. (2017). Dendritic cells and TNF-Related apoptosis inducing ligand (TRAIL) represent new possibilities for sepsis treatment. Insights in Clinical and Cellular Immunology. https://doi.org/10.29328/journal.hcci.1001001
Vancouver
Ganova P. Dendritic cells and TNF-Related apoptosis inducing ligand (TRAIL) represent new possibilities for sepsis treatment. Insights in Clinical and Cellular Immunology. 2017. doi:10.29328/journal.hcci.1001001
BibTeX
@article{Ganova2017,
author = {Ganova, P},
title = {Dendritic cells and TNF-Related apoptosis inducing ligand (TRAIL) represent new possibilities for sepsis treatment},
journal = {Insights in Clinical and Cellular Immunology},
year = {2017},
doi = {10.29328/journal.hcci.1001001}
}
EUVIMED